PLAYTEX DEODORANT TAMPONS, MODEL 34902

• K Number: K020201
• Device Name: PLAYTEX DEODORANT TAMPONS, MODEL 34902
• Manufacturer: PLAYTEX PRODUCTS, INC.
• Date Cleared: 2002-03-12 ( 49 days)
• Product Code: HIL
• Regulation Number: 884.5460

Intended Use

Scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid.

Device Description

Scented, deodorized menstrual tampons for the absorption of menstrual fluid.

Predicate Devices

Not Found

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The device description and performance studies focus on the physical properties and safety of menstrual tampons, with no mention of AI or ML.

Therapeutic

No.
The device, a scented/deodorized menstrual tampon, is intended for the absorption of menstrual fluid, and its performance studies focus on safety and equivalence to predicate devices, not on directly treating or preventing a disease or condition.

Diagnostic

No
Explanation: The device, a scented/deodorized menstrual tampon, is intended for the absorption of menstrual fluid, which is a functional purpose, not a diagnostic one. Its description and performance studies focus on safety and effectiveness for absorption, not on detecting or identifying medical conditions.

SaMD (Software as a Medical Device)

No

The device description clearly states it is a "menstrual tampon," which is a physical, hardware-based medical device. There is no mention of software as the primary or sole component.

IVD (In Vitro Diagnostic)

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

• Intended Use: The intended use is "for the absorption of menstrual fluid." This is a physical function, not a diagnostic test performed on a sample taken from the body.
• Device Description: The description confirms it's a "menstrual tampon for the absorption of menstrual fluid."
• Lack of Diagnostic Elements: There is no mention of analyzing a sample (like blood, urine, or tissue) to detect a disease, condition, or physiological state.
• Performance Studies: The performance studies focus on safety aspects like irritation, toxicity, and TSST-1 toxin testing, which are relevant to a physical device used internally, not a diagnostic test.

IVD devices are designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. This device's function is purely absorptive.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

Scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid.

Product codes (comma separated list FDA assigned to the subject device)

85 HIL

Device Description

Scented, deodorized menstrual tampons for the absorption of menstrual fluid.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical testing referenced for the determination of substantial equivalence includes: Human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritations, agar diffusion and TSST-1 toxin testing.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

Regulation Number and Section

§ 884.5460 Scented or scented deodorized menstrual tampon.

(a)
Identification. A scented or scented deodorized menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. It has scent (i.e., fragrance materials) added for aesthetic purposes (scented menstrual tampon) or for deodorizing purposes (scented deodorized menstrual tampon). This generic type of device does not include menstrual tampons treated with added antimicrobial agents or other drugs.(b)
Classification. Class II (performance standards).

Summary

0

Koaaoi

9. 510(k) SUMMARY

MAR 1 2 2002

SUMMARY OF SAFETY AND EFFECTIVENESS A.

1.	COMPANY NAME	-	Playtex Products Inc.
	ADDRESS	-	75 Commerce Drive
Allendale, New Jersey 07401
	TELEPHONE	-	201-785-8000
	CONTACT PERSON	-	M. Rosengarten
Director, Regulatory, Safety &
International Development
	DATE OF SUMMARY	-	January 18, 2002
2.	DEVICE NAME	-	Playtex Tampons
	CLASSIFICATION NAME	-	Scented, Deodorized Menstrual
Tampons

• 3. The new Playtex tampons are substantially equivalent to the following tampons that have been previously cleared:
  • a. Playtex Deodorant Gentle Glide® in Regular, Super and Super Plus absorbencies
  • Playtex Deodorant Portables® in Regular and Super absorbencies ف
  • Playtex Deodorant Gentle Glide Multipack in Regular and Super C. absorbencies
  • d. Deodorant Slimfits® in Regular absorbency
• 4. The device description is: Scented, deodorized menstrual tampons for the absorption of menstrual fluid.
• న. Playtex tampons are intended to be used as scented, deodorized menstrual tampons for the absorption of menstrual fluid.
• 6. The new tampon has the same technological characteristics as the predicate device. The fiber, string and materials in contact with the vaginal wall are the same or have the same mode of action.
• B. 1. Nonclinical testing referenced for the determination of substantial equivalence includes:

Human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritations, agar diffusion and TSST-1 toxin testing.

• 2. Based on the review of the data referenced in this "510(k) Summary," the Playtex tampons are substantially equivalent to the predicate device in terms of safety and effectiveness.

1

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The logo is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

mar 1 2 2002

Mr. Mark Rosengarten Director, Safety & International & International Development Playtex Products, Inc. Technical Center, 75 Commerce Dr. ALLENDALE NJ 07401-1600

Re: K020201

Trade/Device Name: Playtex Deodorant Tampons # 34902

Regulation Number: 21 CFR 884.5460 Regulation Name: Scented or scented deodorized menstrual tampon

Regulatory Class: II Product Code: 85 HIL Dated: January 18, 2002 Received: January 22, 2002

Dear Mr. Rosengarden:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed nredicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please 11 you toon office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx	[phone]
876.2xxx, 3xxx, 4xxx, 5xxx	[phone]
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx	[phone]
892.2xxx, 3xxx, 4xxx, 5xxx	[phone]
Other	[phone]

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

STATEMENT OF INDICATIONS OF USE PAGE

Page 1 of _1

510(k) Number (if known): KOJOAO

Device Name: Playtex Deodorant Gentle Glide, Playtex Deodorant Portables®, Playtex Deodorant Gentle Glide® Multipack and Playtex Deodorant Slimfits® Tampons Model #34902

Indications For Usc:

Scented or scented, deodorized menstrual tampon for the absorption of menstrual fluid.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

OR

(Optional Format 1-2-96)

Over-The-Counter Use